Press Releases ARCA biopharma, Inc.

Equities

ABIO

US00211Y5069

Real-time Estimate Cboe BZX Other stock markets 02:33:33 2024-05-15 pm EDT			5-day change	1st Jan Change
3.76 ^USD	+13.25%		+10.71%	+118.82%

Apr. 25	ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	North American Morning Briefing : Stock Futures -2-	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	May. 10	BU
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update	Apr. 25	AQ
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO	Apr. 09	PR
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO	Apr. 05	BU
Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka	Apr. 03	PR
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders	Apr. 03	BU
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement	Apr. 03	AQ
ARCA biopharma Announces 2023 Financial Results	Feb. 01	AQ
ARCA biopharma Announces Third Quarter 2023 Financial Results	23-10-18	AQ
ARCA biopharma announces Second Quarter 2023 Financial Results	23-07-24	AQ
ARCA biopharma Announces Second Quarter 2023 Financial Results	23-07-21	AQ
ARCA biopharma : Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options - Form 8-K	23-04-24	PU
ARCA biopharma Announces First Quarter 2023 Financial Results	23-04-24	AQ
ARCA BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	23-04-24	AQ
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update	23-02-27	AQ
ARCA biopharma : Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options - Form 8-K	23-02-24	PU
ARCA BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-02-24	AQ
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update	23-02-24	AQ
ARCA BIOPHARMA, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-02-13	AQ
ARCA BIOPHARMA, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	22-12-19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ARCA biopharma, Inc.

Equities

ABIO

US00211Y5069

Press Releases

Filters